WEBINAR | Reducing Diagnostic Uncertainty | Lumos Diagnostics
WEBINAR | Reducing Diagnostic Uncertainty | Lumos Diagnostics
8.9K views4 months ago
linkedin.com
Lumos Diagnostics secures US$400K Aptatek deal
Lumos Diagnostics secures US$400K Aptatek deal
4 months ago
proactiveinvestors.com
Markets in a Minute: Lumos Diagnostics shines, DroneShield sinks
Markets in a Minute: Lumos Diagnostics shines, DroneShield s…
6 months ago
proactiveinvestors.com
Lumos Diagnostics strengthens U.S. market strategy with new AcuityMD data partnership
Lumos Diagnostics strengthens U.S. market strategy with new AcuityM…
6 months ago
proactiveinvestors.com
Lumos Diagnostics FDA CLIA waiver drives major growth potential in the $1bn US market
Lumos Diagnostics FDA CLIA waiver drives major growth potent…
2 months ago
proactiveinvestors.com
Lumos Diagnostics targets US breakthrough as FebriDx clearance unlocks billion-dollar opportunity
Lumos Diagnostics targets US breakthrough as FebriDx clearanc…
1 month ago
proactiveinvestors.com
Lumos Diagnostics partners with WellStreet Urgent Care to advance FebriDx reimbursement in U.S.
Lumos Diagnostics partners with WellStreet Urgent Care to advanc…
7 months ago
proactiveinvestors.com.au
Broker sees Lumos Diagnostics upside
1 month ago
theaustralian.com.au
2026: The road ahead with Lumos Diagnostics
4 months ago
heraldsun.com.au
Lumos Diagnostics targets key US approvals for FebriDx test - ASX S…
7 months ago
proactiveinvestors.com.au
Lumos CEO: 2025 highlights and 2026 outlook
4 months ago
proactiveinvestors.com.au
Lumos Diagnostics Holdings Limited Appoints Doug Ward as C…
Jun 5, 2022
marketscreener.com
Lumos opens $1b US market for FebriDx diagnostic via CLIA waive…
2 months ago
cairnspost.com.au
Long Shortz with Lumos: FDA approval for FebriDx unlocks billio…
2 months ago
cairnspost.com.au
Lumos Diagnostics | LinkedIn
Nov 6, 2020
linkedin.com
Lumos Diagnostics Holdings Starts Pediatric Study for Point-of-Care …
7 months ago
marketscreener.com
‏Integrated Diagnostics Holdings - IDH‏ | LinkedIn
Sep 5, 2017
linkedin.com
Lumos Diagnostics’ strong full-year results boosted by FDA clearance…
Aug 26, 2024
proactiveinvestors.com.au
Lumos Diagnostics garners US funding to support FebriDx® bact…
Oct 2, 2024
proactiveinvestors.co.uk
7:20
Lumos Diagnostics secures US$400K Aptatek deal
4 months ago
YahooProactive
Lumos Diagnostics’ breakthroughs in paediatric care with FebriDx
Apr 8, 2024
proactiveinvestors.com.au
Lumos Diagnostics surges 140% on major US contract deal
10 months ago
hotcopper.com.au
3:48
Lumos Diagnostics targets key US approvals for FebriDx test - ASX S…
4 views8 months ago
FacebookProactive
Lumos Diagnostics expands FebriDx footprint with Baltic distri…
5 months ago
proactiveinvestors.com
Just the Facts: Lumos Diagnostics seeks US FDA CLIA waiver for Feb…
9 months ago
proactiveinvestors.com.au
Lumos Diagnostics: strategic growth, strong partnerships and p…
2 months ago
proactiveinvestors.com.au
Lumos Diagnostics Secures $2.98 million from BARDA for FebriDx T…
Oct 2, 2024
proactiveinvestors.com.au
Lumos inks deal to advance FebriDx in US
7 months ago
theaustralian.com.au
Lumos Diagnostics’ Sam Lanyon chats antimicrobial care
Oct 9, 2024
theaustralian.com.au
Lumos Diagnostics launches US pediatric study for FebriDx® in par…
7 months ago
proactiveinvestors.com
See more videos
Static thumbnail place holder